Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010.
Identifieur interne : 000482 ( Main/Exploration ); précédent : 000481; suivant : 000483Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010.
Auteurs : Camille Achonu [Canada] ; Laura Rosella ; Jonathan B. Gubbay ; Shelley Deeks ; Anu Rebbapragada ; Tony Mazzulli ; Don Willison ; Julie Foisy ; Allison Mcgeer ; Ian Johnson ; Marie Lafreniere ; Caitlin Johnson ; Jacqueline Willmore ; Carmen Yue ; Natasha S. CrowcroftSource :
- PloS one [ 1932-6203 ] ; 2011.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Facteurs de risque, Femelle, Grippe humaine (épidémiologie), Humains, Jeune adulte, Mâle, Ontario (épidémiologie), Pandémies (), Répartition par âge, Saisons, Sous-type H1N1 du virus de la grippe A (pathogénicité), Sujet âgé, Sujet âgé de 80 ans ou plus, Études de cohortes, Études séroépidémiologiques.
- MESH :
- pathogénicité : Sous-type H1N1 du virus de la grippe A.
- épidémiologie : Grippe humaine, Ontario.
- Adolescent, Adulte, Adulte d'âge moyen, Facteurs de risque, Femelle, Humains, Jeune adulte, Mâle, Pandémies, Répartition par âge, Saisons, Sujet âgé, Sujet âgé de 80 ans ou plus, Études de cohortes, Études séroépidémiologiques.
English descriptors
- KwdEn :
- Adolescent, Adult, Age Distribution, Aged, Aged, 80 and over, Cohort Studies, Female, Humans, Influenza A Virus, H1N1 Subtype (pathogenicity), Influenza, Human (epidemiology), Male, Middle Aged, Ontario (epidemiology), Pandemics (statistics & numerical data), Risk Factors, Seasons, Seroepidemiologic Studies, Young Adult.
- MESH :
- geographic , epidemiology : Ontario.
- epidemiology : Influenza, Human.
- pathogenicity : Influenza A Virus, H1N1 Subtype.
- statistics & numerical data : Pandemics.
- Adolescent, Adult, Age Distribution, Aged, Aged, 80 and over, Cohort Studies, Female, Humans, Male, Middle Aged, Risk Factors, Seasons, Seroepidemiologic Studies, Young Adult.
Abstract
BACKGROUND
We designed a seroprevalence study using multiple testing assays and population sources to estimate the community seroprevalence of pH1N1/09 and risk factors for infection before the outbreak was recognized and throughout the pandemic to the end of 2009/10 influenza season.
METHODS
Residual serum specimens from five time points (between 01/2009 and 05/2010) and samples from two time points from a prospectively recruited cohort were included. The distribution of risk factors was explored in multivariate adjusted analyses using logistic regression among the cohort. Antibody levels were measured by hemagglutination inhibition (HAI) and microneutralization (MN) assays.
RESULTS
Residual sera from 3375 patients and 1024 prospectively recruited cohort participants were analyzed. Pre-pandemic seroprevalence ranged from 2%-12% across age groups. Overall seropositivity ranged from 10%-19% post-first wave and 32%-41% by the end of the 2009/10 influenza season. Seroprevalence and risk factors differed between MN and HAI assays, particularly in older age groups and between waves. Following the H1N1 vaccination program, higher GMT were noted among vaccinated individuals. Overall, 20-30% of the population was estimated to be infected.
CONCLUSIONS
Combining population sources of sera across five time points with prospectively collected epidemiological information yielded a complete description of the evolution of pH1N1 infection.
DOI: 10.1371/journal.pone.0026427
PubMed: 22110586
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010.</title><author><name sortKey="Achonu, Camille" sort="Achonu, Camille" uniqKey="Achonu C" first="Camille" last="Achonu">Camille Achonu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surveillance and Epidemiology, Public Health Ontario, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Surveillance and Epidemiology, Public Health Ontario, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Rosella, Laura" sort="Rosella, Laura" uniqKey="Rosella L" first="Laura" last="Rosella">Laura Rosella</name></author><author><name sortKey="Gubbay, Jonathan B" sort="Gubbay, Jonathan B" uniqKey="Gubbay J" first="Jonathan B" last="Gubbay">Jonathan B. Gubbay</name></author><author><name sortKey="Deeks, Shelley" sort="Deeks, Shelley" uniqKey="Deeks S" first="Shelley" last="Deeks">Shelley Deeks</name></author><author><name sortKey="Rebbapragada, Anu" sort="Rebbapragada, Anu" uniqKey="Rebbapragada A" first="Anu" last="Rebbapragada">Anu Rebbapragada</name></author><author><name sortKey="Mazzulli, Tony" sort="Mazzulli, Tony" uniqKey="Mazzulli T" first="Tony" last="Mazzulli">Tony Mazzulli</name></author><author><name sortKey="Willison, Don" sort="Willison, Don" uniqKey="Willison D" first="Don" last="Willison">Don Willison</name></author><author><name sortKey="Foisy, Julie" sort="Foisy, Julie" uniqKey="Foisy J" first="Julie" last="Foisy">Julie Foisy</name></author><author><name sortKey="Mcgeer, Allison" sort="Mcgeer, Allison" uniqKey="Mcgeer A" first="Allison" last="Mcgeer">Allison Mcgeer</name></author><author><name sortKey="Johnson, Ian" sort="Johnson, Ian" uniqKey="Johnson I" first="Ian" last="Johnson">Ian Johnson</name></author><author><name sortKey="Lafreniere, Marie" sort="Lafreniere, Marie" uniqKey="Lafreniere M" first="Marie" last="Lafreniere">Marie Lafreniere</name></author><author><name sortKey="Johnson, Caitlin" sort="Johnson, Caitlin" uniqKey="Johnson C" first="Caitlin" last="Johnson">Caitlin Johnson</name></author><author><name sortKey="Willmore, Jacqueline" sort="Willmore, Jacqueline" uniqKey="Willmore J" first="Jacqueline" last="Willmore">Jacqueline Willmore</name></author><author><name sortKey="Yue, Carmen" sort="Yue, Carmen" uniqKey="Yue C" first="Carmen" last="Yue">Carmen Yue</name></author><author><name sortKey="Crowcroft, Natasha S" sort="Crowcroft, Natasha S" uniqKey="Crowcroft N" first="Natasha S" last="Crowcroft">Natasha S. Crowcroft</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:22110586</idno><idno type="pmid">22110586</idno><idno type="doi">10.1371/journal.pone.0026427</idno><idno type="wicri:Area/Main/Corpus">000477</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000477</idno><idno type="wicri:Area/Main/Curation">000477</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000477</idno><idno type="wicri:Area/Main/Exploration">000477</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010.</title><author><name sortKey="Achonu, Camille" sort="Achonu, Camille" uniqKey="Achonu C" first="Camille" last="Achonu">Camille Achonu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surveillance and Epidemiology, Public Health Ontario, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Surveillance and Epidemiology, Public Health Ontario, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Rosella, Laura" sort="Rosella, Laura" uniqKey="Rosella L" first="Laura" last="Rosella">Laura Rosella</name></author><author><name sortKey="Gubbay, Jonathan B" sort="Gubbay, Jonathan B" uniqKey="Gubbay J" first="Jonathan B" last="Gubbay">Jonathan B. Gubbay</name></author><author><name sortKey="Deeks, Shelley" sort="Deeks, Shelley" uniqKey="Deeks S" first="Shelley" last="Deeks">Shelley Deeks</name></author><author><name sortKey="Rebbapragada, Anu" sort="Rebbapragada, Anu" uniqKey="Rebbapragada A" first="Anu" last="Rebbapragada">Anu Rebbapragada</name></author><author><name sortKey="Mazzulli, Tony" sort="Mazzulli, Tony" uniqKey="Mazzulli T" first="Tony" last="Mazzulli">Tony Mazzulli</name></author><author><name sortKey="Willison, Don" sort="Willison, Don" uniqKey="Willison D" first="Don" last="Willison">Don Willison</name></author><author><name sortKey="Foisy, Julie" sort="Foisy, Julie" uniqKey="Foisy J" first="Julie" last="Foisy">Julie Foisy</name></author><author><name sortKey="Mcgeer, Allison" sort="Mcgeer, Allison" uniqKey="Mcgeer A" first="Allison" last="Mcgeer">Allison Mcgeer</name></author><author><name sortKey="Johnson, Ian" sort="Johnson, Ian" uniqKey="Johnson I" first="Ian" last="Johnson">Ian Johnson</name></author><author><name sortKey="Lafreniere, Marie" sort="Lafreniere, Marie" uniqKey="Lafreniere M" first="Marie" last="Lafreniere">Marie Lafreniere</name></author><author><name sortKey="Johnson, Caitlin" sort="Johnson, Caitlin" uniqKey="Johnson C" first="Caitlin" last="Johnson">Caitlin Johnson</name></author><author><name sortKey="Willmore, Jacqueline" sort="Willmore, Jacqueline" uniqKey="Willmore J" first="Jacqueline" last="Willmore">Jacqueline Willmore</name></author><author><name sortKey="Yue, Carmen" sort="Yue, Carmen" uniqKey="Yue C" first="Carmen" last="Yue">Carmen Yue</name></author><author><name sortKey="Crowcroft, Natasha S" sort="Crowcroft, Natasha S" uniqKey="Crowcroft N" first="Natasha S" last="Crowcroft">Natasha S. Crowcroft</name></author></analytic><series><title level="j">PloS one</title><idno type="eISSN">1932-6203</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Age Distribution</term><term>Aged</term><term>Aged, 80 and over</term><term>Cohort Studies</term><term>Female</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype (pathogenicity)</term><term>Influenza, Human (epidemiology)</term><term>Male</term><term>Middle Aged</term><term>Ontario (epidemiology)</term><term>Pandemics (statistics & numerical data)</term><term>Risk Factors</term><term>Seasons</term><term>Seroepidemiologic Studies</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Facteurs de risque</term><term>Femelle</term><term>Grippe humaine (épidémiologie)</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Ontario (épidémiologie)</term><term>Pandémies ()</term><term>Répartition par âge</term><term>Saisons</term><term>Sous-type H1N1 du virus de la grippe A (pathogénicité)</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études de cohortes</term><term>Études séroépidémiologiques</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ontario</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Pandemics</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term><term>Ontario</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Age Distribution</term><term>Aged</term><term>Aged, 80 and over</term><term>Cohort Studies</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Risk Factors</term><term>Seasons</term><term>Seroepidemiologic Studies</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Pandémies</term><term>Répartition par âge</term><term>Saisons</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études de cohortes</term><term>Études séroépidémiologiques</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>We designed a seroprevalence study using multiple testing assays and population sources to estimate the community seroprevalence of pH1N1/09 and risk factors for infection before the outbreak was recognized and throughout the pandemic to the end of 2009/10 influenza season.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>Residual serum specimens from five time points (between 01/2009 and 05/2010) and samples from two time points from a prospectively recruited cohort were included. The distribution of risk factors was explored in multivariate adjusted analyses using logistic regression among the cohort. Antibody levels were measured by hemagglutination inhibition (HAI) and microneutralization (MN) assays.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Residual sera from 3375 patients and 1024 prospectively recruited cohort participants were analyzed. Pre-pandemic seroprevalence ranged from 2%-12% across age groups. Overall seropositivity ranged from 10%-19% post-first wave and 32%-41% by the end of the 2009/10 influenza season. Seroprevalence and risk factors differed between MN and HAI assays, particularly in older age groups and between waves. Following the H1N1 vaccination program, higher GMT were noted among vaccinated individuals. Overall, 20-30% of the population was estimated to be infected.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Combining population sources of sera across five time points with prospectively collected epidemiological information yielded a complete description of the evolution of pH1N1 infection.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22110586</PMID><DateCompleted><Year>2012</Year><Month>03</Month><Day>26</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>11</Issue><PubDate><Year>2011</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010.</ArticleTitle><Pagination><MedlinePgn>e26427</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0026427</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We designed a seroprevalence study using multiple testing assays and population sources to estimate the community seroprevalence of pH1N1/09 and risk factors for infection before the outbreak was recognized and throughout the pandemic to the end of 2009/10 influenza season.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Residual serum specimens from five time points (between 01/2009 and 05/2010) and samples from two time points from a prospectively recruited cohort were included. The distribution of risk factors was explored in multivariate adjusted analyses using logistic regression among the cohort. Antibody levels were measured by hemagglutination inhibition (HAI) and microneutralization (MN) assays.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Residual sera from 3375 patients and 1024 prospectively recruited cohort participants were analyzed. Pre-pandemic seroprevalence ranged from 2%-12% across age groups. Overall seropositivity ranged from 10%-19% post-first wave and 32%-41% by the end of the 2009/10 influenza season. Seroprevalence and risk factors differed between MN and HAI assays, particularly in older age groups and between waves. Following the H1N1 vaccination program, higher GMT were noted among vaccinated individuals. Overall, 20-30% of the population was estimated to be infected.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Combining population sources of sera across five time points with prospectively collected epidemiological information yielded a complete description of the evolution of pH1N1 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Achonu</LastName><ForeName>Camille</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surveillance and Epidemiology, Public Health Ontario, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosella</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Gubbay</LastName><ForeName>Jonathan B</ForeName><Initials>JB</Initials></Author><Author ValidYN="Y"><LastName>Deeks</LastName><ForeName>Shelley</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Rebbapragada</LastName><ForeName>Anu</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Mazzulli</LastName><ForeName>Tony</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Willison</LastName><ForeName>Don</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Foisy</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>McGeer</LastName><ForeName>Allison</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>LaFreniere</LastName><ForeName>Marie</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Caitlin</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Willmore</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Yue</LastName><ForeName>Carmen</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Crowcroft</LastName><ForeName>Natasha S</ForeName><Initials>NS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>08</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>09</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22110586</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0026427</ArticleId><ArticleId IdType="pii">PONE-D-11-16549</ArticleId><ArticleId IdType="pmc">PMC3215698</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Euro Surveill. 2010 Oct 07;15(40):</Citation><ArticleIdList><ArticleId IdType="pubmed">20946757</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Vaccine Immunol. 2011 Mar;18(3):520-2</Citation><ArticleIdList><ArticleId IdType="pubmed">21228145</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Nov 12;361(20):1945-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19745214</ArticleId></ArticleIdList></Reference><Reference><Citation>Prev Med. 2011 Jan;52(1):71-4</Citation><ArticleIdList><ArticleId IdType="pubmed">21047527</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2010 Nov 23;182(17):1851-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20956500</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011 Jan 25;6(1):e16164</Citation><ArticleIdList><ArticleId IdType="pubmed">21283570</ArticleId></ArticleIdList></Reference><Reference><Citation>Br Med Bull. 1979 Jan;35(1):69-75</Citation><ArticleIdList><ArticleId IdType="pubmed">367490</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Infect Dis. 2011 Jan 14;11:16</Citation><ArticleIdList><ArticleId IdType="pubmed">21235795</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2010 Apr 14;303(14):1383-91</Citation><ArticleIdList><ArticleId IdType="pubmed">20388894</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Jun 1;50(11):1487-92</Citation><ArticleIdList><ArticleId IdType="pubmed">20415539</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2010 Dec 14;182(18):1981-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21059773</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2010 Apr 06;7(4):e1000258</Citation><ArticleIdList><ArticleId IdType="pubmed">20386731</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Mar 27;375(9720):1100-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20096450</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Sep 07;5(9):e12562</Citation><ArticleIdList><ArticleId IdType="pubmed">20830210</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2010 Aug 05;15(31):</Citation><ArticleIdList><ArticleId IdType="pubmed">20738992</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Curr. 2010 Feb 24;2:RRN1148</Citation><ArticleIdList><ArticleId IdType="pubmed">20191082</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2010 Feb 04;15(5):</Citation><ArticleIdList><ArticleId IdType="pubmed">20144443</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Oct 14;5(10):e13211</Citation><ArticleIdList><ArticleId IdType="pubmed">20976224</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Jul 14;5(7):e11601</Citation><ArticleIdList><ArticleId IdType="pubmed">20644650</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Nov 15;51(10):1184-91</Citation><ArticleIdList><ArticleId IdType="pubmed">20964521</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Sep 15;51(6):668-77</Citation><ArticleIdList><ArticleId IdType="pubmed">20687838</ArticleId></ArticleIdList></Reference><Reference><Citation>Wkly Epidemiol Rec. 2009 Nov 20;84(47):485-91</Citation><ArticleIdList><ArticleId IdType="pubmed">19928301</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2007 May;11(3):268-72</Citation><ArticleIdList><ArticleId IdType="pubmed">16905350</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010 Jun 09;5(6):e11036</Citation><ArticleIdList><ArticleId IdType="pubmed">20543954</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(11):e28063</Citation><ArticleIdList><ArticleId IdType="pubmed">22132212</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2010 Oct 5;182(14):1522-4</Citation><ArticleIdList><ArticleId IdType="pubmed">20823167</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Dec 17;361(25):2405-13</Citation><ArticleIdList><ArticleId IdType="pubmed">19745216</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(8):e21828</Citation><ArticleIdList><ArticleId IdType="pubmed">21850217</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country></list><tree><noCountry><name sortKey="Crowcroft, Natasha S" sort="Crowcroft, Natasha S" uniqKey="Crowcroft N" first="Natasha S" last="Crowcroft">Natasha S. Crowcroft</name><name sortKey="Deeks, Shelley" sort="Deeks, Shelley" uniqKey="Deeks S" first="Shelley" last="Deeks">Shelley Deeks</name><name sortKey="Foisy, Julie" sort="Foisy, Julie" uniqKey="Foisy J" first="Julie" last="Foisy">Julie Foisy</name><name sortKey="Gubbay, Jonathan B" sort="Gubbay, Jonathan B" uniqKey="Gubbay J" first="Jonathan B" last="Gubbay">Jonathan B. Gubbay</name><name sortKey="Johnson, Caitlin" sort="Johnson, Caitlin" uniqKey="Johnson C" first="Caitlin" last="Johnson">Caitlin Johnson</name><name sortKey="Johnson, Ian" sort="Johnson, Ian" uniqKey="Johnson I" first="Ian" last="Johnson">Ian Johnson</name><name sortKey="Lafreniere, Marie" sort="Lafreniere, Marie" uniqKey="Lafreniere M" first="Marie" last="Lafreniere">Marie Lafreniere</name><name sortKey="Mazzulli, Tony" sort="Mazzulli, Tony" uniqKey="Mazzulli T" first="Tony" last="Mazzulli">Tony Mazzulli</name><name sortKey="Mcgeer, Allison" sort="Mcgeer, Allison" uniqKey="Mcgeer A" first="Allison" last="Mcgeer">Allison Mcgeer</name><name sortKey="Rebbapragada, Anu" sort="Rebbapragada, Anu" uniqKey="Rebbapragada A" first="Anu" last="Rebbapragada">Anu Rebbapragada</name><name sortKey="Rosella, Laura" sort="Rosella, Laura" uniqKey="Rosella L" first="Laura" last="Rosella">Laura Rosella</name><name sortKey="Willison, Don" sort="Willison, Don" uniqKey="Willison D" first="Don" last="Willison">Don Willison</name><name sortKey="Willmore, Jacqueline" sort="Willmore, Jacqueline" uniqKey="Willmore J" first="Jacqueline" last="Willmore">Jacqueline Willmore</name><name sortKey="Yue, Carmen" sort="Yue, Carmen" uniqKey="Yue C" first="Carmen" last="Yue">Carmen Yue</name></noCountry><country name="Canada"><noRegion><name sortKey="Achonu, Camille" sort="Achonu, Camille" uniqKey="Achonu C" first="Camille" last="Achonu">Camille Achonu</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000482 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000482 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeCanadaV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:22110586
|texte= Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:22110586" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV3
| This area was generated with Dilib version V0.6.35. |  |